Olfactory hallucination

Olfactory hallucination is the perception of a smell that has no source in the immediate environment.

As a drug effect it is acute and strongly dose-dependent, appearing at higher doses and fading as the substance wears off; this sets it apart from persistent olfactory disturbance. It ranges from faint, transient impressions of a scent to vivid, sustained phantom odors indistinguishable from real ones.

Olfactory hallucinations are among the rarer perceptual disturbances reported across psychoactive substances. They are most commonly induced at high doses under psychedelics such as psilocybin mushrooms, 4-AcO-DMT, and 4-AcO-MET, and under deliriants such as diphenhydramine and Datura; they also appear under dissociatives such as 3-Cl-PCP and 3-HO-PCP, and occasionally under stimulants such as methamphetamine and modafinil.

Olfactory hallucination is felt as a smell that arrives fully formed — specific, located, and convincing — with no visible origin. The scent may be pleasant, neutral, or distinctly unpleasant: food, smoke, flowers, rot, or something that resists easy naming.

Searching the room and finding nothing tends to sharpen rather than dissolve it; attention drawn to the smell does not resolve it. At higher doses the phantom odor can shift or layer alongside other sensory distortions, becoming one thread in a broader perceptual reorganization.

Olfactory hallucination arises through different pathways depending on the drug class:

• Psychedelics — act on 5-HT2A receptors, broadly disrupting sensory filtering; olfactory cortex activity becomes decoupled from peripheral input, allowing internal patterns to register as apparent smells.
• Deliriants — block muscarinic acetylcholine receptors, producing frank hallucinations across modalities including smell.
• Dissociatives — NMDA receptor antagonism disrupts sensory gating; phantom percepts can emerge in any modality.
• Stimulants — at high doses, dopaminergic excess can produce perceptual disturbances, olfactory ones among them.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. It is a high-dose phenomenon; at lower exposures it rarely appears at all. Set and setting matter less here than with emotional effects — olfactory hallucinations are more closely tied to dose and individual neurochemistry than to mood or surroundings.

Prior history with a substance offers some prediction: those who have encountered cross-modal distortions before are likelier to encounter them again. Differences in olfactory sensitivity and receptor expression likely account for much of the remaining variation.